AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.
Company WebsiteSU9516 is a potent, selective cdk2 inhibitor. It inhibits pRb phosphorylation causing enhanced pRB/E2F complex formation and induces G1 and G2-M cell cycle arrest.
More Information Supplier PageSulbactam is a beta-lactamase inhibitor with an average IC50 of 0.8 ??M.
More Information Supplier PageSulbactam is a beta-lactamase inhibitor with an average IC50 of 0.8 ??M.
More Information Supplier PageSulbactam is a beta-lactamase inhibitor with an average IC50 of 0.8 ??M.
More Information Supplier PageSulbactam is a beta-lactamase inhibitor with an average IC50 of 0.8 ??M.
More Information Supplier PageSulbactam is a beta-lactamase inhibitor with an average IC50 of 0.8 ??M.
More Information Supplier PageSulfo-NHS-LC-Biotin is an intermediate length, water-soluble biotinyltation reagent used to attach biotin to primary amines.
More Information Supplier PageSulfo-NHS-LC-Biotin is an intermediate length, water-soluble biotinyltation reagent used to attach biotin to primary amines.
More Information Supplier PageSulfo-NHS-SS-Biotin is a water-soluble, NHS-ester biotinylation reagent.
More Information Supplier PageSulfo-NHS-SS-Biotin is a water-soluble, NHS-ester biotinylation reagent.
More Information Supplier PageSulindac(Clinoril) is a non-steroidal anti-inflammatory drug of the arylalkanoic acid class.
More Information Supplier PageSulindac(Clinoril) is a non-steroidal anti-inflammatory drug of the arylalkanoic acid class.
More Information Supplier PageSulindac(Clinoril) is a non-steroidal anti-inflammatory drug of the arylalkanoic acid class.
More Information Supplier PageSulindac(Clinoril) is a non-steroidal anti-inflammatory drug of the arylalkanoic acid class.
More Information Supplier PageSulindac(Clinoril) is a non-steroidal anti-inflammatory drug of the arylalkanoic acid class.
More Information Supplier PageSunitinib is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST).
More Information Supplier PageSunitinib is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST).
More Information Supplier PageSunitinib is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST).
More Information Supplier PageSunitinib is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST).
More Information Supplier PageSunitinib is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST).
More Information Supplier PageSVT-40776 is a novel M3 muscarinic receptor antagonist, for the treatment of overactive bladder.
More Information Supplier PageSVT-40776 is a novel M3 muscarinic receptor antagonist, for the treatment of overactive bladder.
More Information Supplier PageSVT-40776 is a novel M3 muscarinic receptor antagonist, for the treatment of overactive bladder.
More Information Supplier PageSVT-40776 is a novel M3 muscarinic receptor antagonist, for the treatment of overactive bladder.
More Information Supplier PageSW033291 is a small-molecule inhibitor of 15-PGDH (Ki=0.1 nM) that increases prostaglandin PGE2 levels in bone marrow and other tissues.
More Information Supplier PageSW033291 is a small-molecule inhibitor of 15-PGDH (Ki=0.1 nM) that increases prostaglandin PGE2 levels in bone marrow and other tissues.
More Information Supplier PageSW033291 is a small-molecule inhibitor of 15-PGDH (Ki=0.1 nM) that increases prostaglandin PGE2 levels in bone marrow and other tissues.
More Information Supplier PageSwertiamarin has shown potential as antiatherogenic agent by inhibiting HMG-CoA reductase activity in high cholesterol fed rats.
More Information Supplier PageSwertiamarin has shown potential as antiatherogenic agent by inhibiting HMG-CoA reductase activity in high cholesterol fed rats.
More Information Supplier PageSwertiamarin has shown potential as antiatherogenic agent by inhibiting HMG-CoA reductase activity in high cholesterol fed rats.
More Information Supplier PageSYN115 is an orally administered, potent and selective inhibitor of the adenosine 2a (A2a) receptor that is being developed initially for the treatment of Parkinson?€?s disease, but may also have utility in other CNS disorders.
More Information Supplier PageSYN115 is an orally administered, potent and selective inhibitor of the adenosine 2a (A2a) receptor that is being developed initially for the treatment of Parkinson?€?s disease, but may also have utility in other CNS disorders.
More Information Supplier PageSYN115 is an orally administered, potent and selective inhibitor of the adenosine 2a (A2a) receptor that is being developed initially for the treatment of Parkinson?€?s disease, but may also have utility in other CNS disorders.
More Information Supplier PageSYN115 is an orally administered, potent and selective inhibitor of the adenosine 2a (A2a) receptor that is being developed initially for the treatment of Parkinson?€?s disease, but may also have utility in other CNS disorders.
More Information Supplier PageSynephrine (Oxedrine) is an amine compound commonly used for weight loss.
More Information Supplier PageSynephrine (Oxedrine) is an amine compound commonly used for weight loss.
More Information Supplier PageSyringic acid is a naturally occurring O-methylated trihydroxybenzoic acid, a type of chemical compound.
More Information Supplier PageSyringic acid is a naturally occurring O-methylated trihydroxybenzoic acid, a type of chemical compound.
More Information Supplier PageSyringic acid is a naturally occurring O-methylated trihydroxybenzoic acid, a type of chemical compound.
More Information Supplier PageSyringin is a natural chemical compound first isolated from the bark of lilac (Syringa vulgaris) by Meillet in 1841.
More Information Supplier PageSyringin is a natural chemical compound first isolated from the bark of lilac (Syringa vulgaris) by Meillet in 1841.
More Information Supplier PageSyringin is a natural chemical compound first isolated from the bark of lilac (Syringa vulgaris) by Meillet in 1841.
More Information Supplier PageT-1095 is a potent and selective inhibitor of Na+-glucose cotransporters (SGLTs).
More Information Supplier Page
